Autologous Osteo-periosteal Cylinder Graft Transplantation for Hepple V Osteochondral Lesions of the Talus
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: autologous osteo-periosteal cylinder graft transplantation, autologous osteochondral graft transplantation, autologous osteo-periosteal cylinder graft.
- Who it may be relevant to
- Registry conditions: Osteochondral; Defect. Basic parameters: 18 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Clinical Study of Autologous Osteo-periosteal Cylinder Graft Transplantation for Hepple V Osteochondral Lesions of the Talus
Overview
The trial evaluates the clinical efficacy and safety of autologous osteo-periosteal cylinder graft transplantation for Hepple V osteochondral lesions of the talus. Half of participants will receive autologous osteo-periosteal cylinder graft transplantation, while the other will receive osteochondral graft transplantation as a control group.
Detailed description
Autologous osteo-periosteal cylinder graft surface is a periosteal structure, with the ability of repairment to cartilage, periosteum is closely connected to the cortical bone, then the deep loose cancellous bone.The objective of the study is to evaluate the clinical efficacy of autologous osteo-periosteal cylinder graft transplantation for Hepple V osteochondral lesions of the talus by randomized controlled trial. 70 patients with clinically diagnosed Hepple V talus osteochondral lesions according to 1: 1 were divided into experimental group and control group. The experimental group will be treated with autologous osteo-periosteal cylinder graft transplantation under arthroscopy. The control group will be treated with autologous osteochondral graft under arthroscopy. The patients will be treated by the same surgeon in this study group. Postoperative MRI MOCART evaluation, clinical AOFAS score, VAS score, Tegner score, and the secondary arthroscopy ICRS score will be selected as the measures of outcome. The incidence of adverse events will be recorded.
Interventions
- Procedure autologous osteo-periosteal cylinder graft transplantation
Autologous osteo-periosteal cylinder graft transplantation is a novel treatment for Hepple V osteochondral lesions of the talus. - Procedure autologous osteochondral graft transplantation
Autologous osteochondral graft transplantation is the most common treatment for Hepple V osteochondral lesions of the talus. - Device autologous osteo-periosteal cylinder graft
Autologous osteo-periosteal cylinder graft is taken from ilium.
Primary outcome measures
- American Orthopaedic Foot & Ankle Society(AOFAS) ankle-hindfoot score [Time frame: 4 years]
Secondary outcome measures (4)
- International Cartilage Repair Society(ICRS) score [Time frame: 4 years]
- Magnetic Resonance Observation of cartilage repair tissue(MOCART) score [Time frame: 4 years]
- Tegner activity level score [Time frame: 4 years]
- Visual analogue scale [Time frame: 4 years]
Eligibility criteria
Inclusion criteria
- 18-50 years old, male or female
- Chronic pain in the ankle, confirmed by ankle joint MRI as Hepple V osteo-chondral lesions of the talus
- Using rest/external use/oral non-steroidal anti-inflammatory drugs and other conservative treatment for more than 3 months ineffective
- Patients voluntarily participated in clinical trials, signed informed consent, with clinical follow-up
Exclusion criteria
- In the last 6 months patients participated in other drug or medical device clinical trials
- Line of force in ankle is not correct (varus or valgus> 5 degrees)
- Grade III ankle collateral ligament injury
- Chronic specific synovitis (rheumatoid, pigmented villonodular synovitis, etc.)
- Joint fibrosis, ankylosis, activity was significantly limited
- Moderate and severe osteoarthritis
- There are MRI contraindications
- Hemophilia patients
- The general condition of patients can not tolerate surgery
- Pregnant or planned pregnant women and lactating women
- Abnormal mental capacity without autonomy
- Other conditions in which the doctor can not decide to participate in the trial
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
China · 1 center
- Institute of Sports Medicine — Beijing
Publications
- Yang S, Hu F, Shao Q, Zhang Z, Liu X, Jiang Y, Jiang D, Xie X, Jiao C, Hu Y, Shi W, Guo Q. Autologous Osteoperiosteal Transplantation Versus Autologous Osteochondral Transplantation for Large Cystic Osteochondral Lesions of the Medial Talus: 2-Year Results From a Prospective Randomized Controlled Trial. Am J Sports Med. 2025 Sep;53(11):2642-2651. doi: 10.1177/03635465251361505. Epub 2025 Aug 19. PMID 40828751
- Deng E, Shi W, Jiang Y, Guo Q. Comparison of autologous osteoperiosteal cylinder and osteochondral graft transplantation in the treatment of large cystic osteochondral lesions of the talus (OLTs): a protocol for a non-inferiority randomised controlled trial. BMJ Open. 2020 Feb 9;10(2):e033850. doi: 10.1136/bmjopen-2019-033850. PMID 32041859
Identifiers
NCT: NCT03347877 · PKU-GUO-01